Skip to main content
    E

    EyePoint, Inc (EYPT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.30
    -0.01 (-3.80%)

    Market Cap: $35.00M

    Last updated: Nov 17, 2026 at 4:28 PM ET

    EyePoint, Inc (EYPT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    EyePoint (EYPT) has a market cap of $35.00M. It kept -13286.38% of revenue as net income over the last 12 months. It holds $83.21M more cash than debt, 237.73% of its market cap.

    Total Valuation

    Market Cap$35.00M
    Latest price (Nov 17, 2026)$0.30

    Key Dates

    The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 2, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 3.12% in the quarter ended Sep 30, 2026 and grew 28.03% a year over 2 years.

    Shares Outstanding89.25M
    Shares Change (YoY)+27.19%
    Shares Change (QoQ)+3.12%
    Share Count Growth (2Y CAGR)+28.03%

    Valuation Ratios

    Sales and book value multiples are 10.2x and 0.2x. Its year-end P/S ranged from 1.3x to 40.8x from 2016 to 2025.

    P/S Ratio10.2x
    Forward P/S15.8x
    P/B Ratio0.2x

    Valuation history and multiples

    Price Statistics

    The stock is down 97.44% over 52 weeks and trades 86.11% below its 50-day average.

    Beta (1Y)1.18
    52-Week Change-97.44%
    1-Month Change-32.75%
    3-Month Change-95.30%
    6-Month Change-97.50%
    5-Year Change-96.96%
    10-Year Change-98.32%
    Total Return (1Y)-97.44%
    Total Return (3Y CAGR)-64.56%
    Total Return (5Y CAGR)-55.22%
    Max Drawdown (1Y)-98.43%
    Max Drawdown (3Y)-99.00%
    Sharpe Ratio (1Y)-1.66
    Correlation with SPY (1Y)0.07
    50-Day Average$2.16
    200-Day Average$10.10
    52-Week Range$0.28 to $19.11
    RSI (14 Days)18.1
    Average Volume (20 Days)7.82M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.30x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio3.30x
    Quick Ratio3.25x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -315.67% over the last 12 months, against a 5-year average of -55.81%.

    Return on Equity (ROE)-315.67%
    Return on Assets (ROA)-206.17%
    Return on Capital Employed (ROCE)-268.24%
    ROE (5Y Average)-55.81%
    ROA (5Y Average)-38.76%
    ROIC (5Y Average)-43.27%
    Asset Turnover0.01x
    Inventory Turnover1.16x
    Receivables Turnover14.94x
    Cash Conversion Cycle-2535 days

    Scores

    EYPT has an Altman Z-Score of -17.50, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-17.50
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $2.58M over the last 12 months is down 93.91% from the 12 months before.

    Revenue$2.58M
    Revenue Growth (YoY)-93.91%
    Gross Profit$512.00K
    Operating Income-$351.83M
    Pretax Income-$342.39M
    Net Income-$342.52M
    EBITDA-$341.45M
    EBIT-$342.35M
    Reported EPS (TTM)-$3.96

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 65.31% of the $166.14M in total assets.

    Cash and Equivalents$83.21M
    Total Debt$0
    Net Cash$83.21M
    Net Cash Per Share$0.93
    Working Capital$88.48M
    Shareholder Equity$108.51M
    Book Value Per Share$1.22
    Total Assets$166.14M
    Total Liabilities$57.63M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $4.39M of capital spending, operating cash flow left -$299.15M of free cash flow.

    Operating Cash Flow-$294.76M
    Capital Expenditures$4.39M
    Free Cash Flow-$299.15M
    FCF Per Share-$3.57
    Depreciation and Amortization$4.73M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -13647.32%.

    Gross Margin19.86%
    Operating Margin-13647.32%
    Pretax Margin-13281.11%
    Net Margin-13286.38%
    EBITDA Margin-13244.69%
    EBIT Margin-13279.83%
    FCF Margin-11603.92%
    Gross Margin (5Y Average)90.23%

    Growth

    Revenue fell 8.83% a year over 3 years.

    Revenue Growth (3Y CAGR)-8.83%
    Revenue Growth (5Y CAGR)-14.55%
    Book Value Per Share Growth (2Y CAGR)-23.60%
    Tangible Book Per Share Growth (2Y CAGR)-23.60%

    Revenue and profit by year

    Dividends and Yields

    EYPT does not pay a dividend. Its free cash flow yield is -1132.81%.

    FCF Yield-1132.81%
    Buyback Yield-798.54%
    Shareholder Yield-798.54%

    Stock Splits

    The last split was a 1-for-10 reverse split on Dec 9, 2020.

    Last Split DateDec 9, 2020
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 5 similar companies, EYPT has the 3rd highest P/S.

    P/S Ratio10.2x vs 9.7x median
    Revenue Growth (Trailing 4 Quarters, YoY)-93.91% vs -32.90% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -58.64% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-58.64%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EYPT

    What is EYPT's market cap?

    EyePoint has a market cap of $35.00M.

    How many shares of EYPT are outstanding?

    EyePoint has 89.25M shares outstanding. The count is up 27.19% from a year earlier.

    Does EYPT pay a dividend?

    No. EyePoint does not pay a dividend.

    How much debt does EYPT have?

    EyePoint has $0 of total debt and $83.21M of cash and equivalents, a net cash position of $83.21M.